History
The path of ASTERASYS
2020
- March
- Acquisition of ISO 13485: 2016 DNV CE for Futera Dots
- Acquisition of KC Certification for Aqua Peel
- May
- Acquisition of KFDA for Futera Dots
- Acquisition of Brazil’s INMETRO and ANVISA for Liftera-A / Liftera-V
- June
- Acquisition of KFDA for 10THERA
2019
- January
- Transferred the headquarters to Seongsu-dong, Seongdong-gu, Seoul Metropolitan City
- March
- Transferred the factory (factory in Seongsu-dong)
- May
- Launched a specialized aesthetic brand, Bellerev
- Launched the economical cosmetics brand, Dr. Seolleim
- June
- Venture Company confirmation
- August
- Launched products including Belle-Up, Belle-Clean, Belle-Shine and Belle-Mix
- September
- Launched a new product, Liftera-A
- October
- Acquisition of certification for ISO 13485: 2016 MTIC CE change
- December
- Received $5 Million Export Tower
- Acquisition of certification for KFDA GMP change
2018
- January
- Changed the company name to ASTERASYS
- March
- Acquisition of China’s CVC Certification for Liftera-V
- April
- Acquisition of an export license for AquaPeel Tera
- May
- Acquisition of an export license for Futera Dots
- Acquisition of an export license for RF Tera
- June
- Establishment of an R&D Institute
- August
- Acquisition of CE Certification for Liftera-A (Medical Device (MD) Mark labeling)
- October
- Acquisition of ISO13485 Certification for medical device
- November
- Secured an investment of 4 billion Won from Premier Partners Ltd.
2017
- January
- Obtained permission to export license for Liftera-V
- February
- Launched Pen Applicator (TDT Technology)
- March
- HIFU PLUS certified and approved by KFDA
2016
- January
- KGMP Acquisition
- February
- Certified by ISO13485
- March
- Liftera-A certified for domestic and export licenses
- June
- Launched Liftera-P in Korea and obtained permission for export license
- July
- Launched InBalance 300 in Korea and obtained permission for export license
2015
- July
- Establishment of DAIHAN Biomedical Co., Ltd.